Abstract
Seventy-six evaluable patients with ovarian carcinoma stages FIGO IIb, IIe, III, and IV, either received cis-platin (P) (80mg/m2 iv. day 1), melphalan (PAM) (12mg/m2 i.v. day 2) and hexamethylmelamine (IIEXAPAMP) (135mg/m2 orally days 8 to 21) or the same dose of cis-platin and melphalan but no hexamethylmelamine (PAMP) every four weeks. In 24 patients (32%) a surgically ascertained CR was achieved. 16 of these received follow-up radiation treatment to the whole abdomen. At present 19 patients are without relapse (average time 24 months). The trial has not been concluded. Particularly no predictions can be made on the value of follow-up radiation therapy in obtaining long-term remission rates.
Original language | English |
---|---|
Pages (from-to) | 383-387 |
Number of pages | 5 |
Journal | Oncology Research and Treatment |
Volume | 8 |
Issue number | 6 |
DOIs | |
Publication status | Published - 1985 |
Keywords
- Chemotherapy
- Ovarian cancer
- RadiationReferences
ASJC Scopus subject areas
- Cancer Research
- Hematology
- Oncology